Details

Autor(en) / Beteiligte

• Wilcox, Ryan A.

Titel

Mogamulizumab: 2 birds, 1 stone

Ist Teil von

• Blood, 2015-03, Vol.125 (12), p.1847-1848

Ort / Verlag

United States: Elsevier Inc

Erscheinungsjahr

2015

Quelle

MEDLINE

Beschreibungen/Notizen

• In this issue of Blood, Duvic et al demonstrate that mogamulizumab, a humanized monoclonal antibody targeting the chemokine receptor CCR4, is well tolerated and has significant clinical activity (overall response rate 36.8%, median duration of response 10.4 months) in heavily pretreated patients with mycosis fungoides (MF) and Sézary syndrome (SS).